Drug news
Spiriva (Boehringer) in Phase III for Asthma
Boehringer announced that a comprehensive confirmatory Phase III trial program named UniTinA-asthma is ongoing to fully evaluate the potential of the long-acting bronchodilator, Spiriva(tiotropium bromide)in the treatment of Asthma in pediatric, adolescent and adult patients.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.